Rationale and Strategies for Early Detection and Management of Diabetic Kidney Disease

Radbill, Brian; Murphy, Barbara; LeRoith, Derek
December 2008
Mayo Clinic Proceedings;Dec2008, Vol. 83 Issue 12, p1373
Academic Journal
Diabetic kidney disease (DKD) occurs in 20% to 40% of patients with diabetes mellitus and is the leading cause of chronic kidney disease and end-stage renal disease in the United States. Despite the American Diabetes Association and the National Kidney Foundation advocating annual screening of diabetic patients, DKD remains underdiagnosed in the diabetic population. Early recognition of diabetic nephropathy by health care professionals is vital for proper management. The presence of microalbuminuria is particularly important as even low levels of dipstick-negative albuminuria indicate early disease long before a diminished glomerular filtration rate and are associated with an elevated cardiovascular disease risk. Like all forms of chronic kidney disease, DKD causes a progressive decline in renal function that, despite current treatment strategies, is largely irreversible. Many patients with DKD might be expected to develop end-stage renal disease, but many more patients will likely die of a cardiovascular event before renal replacement therapy is needed. Therefore, a renewed focus on cardiovascular risk factor reduction and a timely nephrology consultation with an emphasis on patient education is essential to proper DKD management.


Related Articles

  • Cardiovascular risk in diabetic kidney disease: A model of chronic renal disease. Thomas, S. M.; Viberti, G. C. // Kidney International Supplement;Sep2005, Issue 98, pS18 

    Discusses cardiovascular risk in diabetic kidney disease. Reasons why kidney disease and cardiovascular diseases (CVD) are associated; Prevention of CVD in patients with diabetic kidney disease.

  • Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes. Qunibi, Wajeh Y.; Abouzahr, Fadi; Mizani, Mohammad R.; Nolan, Charles R.; Arya, Rector; Hunt, Kelly J. // Kidney International;Jul2005, Vol. 68 Issue 1, p271 

    Background: Cardiovascular calcification (CVC) is common and severe in patients with end-stage renal disease on dialysis. However, the prevalence and severity of CVC is less well documented in patients with chronic kidney disease (CKD) not yet on dialysis. Methods:...

  • Risk factors / Laboratory methods for progression 1.  // Nephrology Dialysis Transplantation;Jul2007 Supplement 6, Vol. 22, pvi59 

    This section presents abstracts on nephrology-related topics including the cardiovascular disease (CVD) parameters in patients with chronic kidney disease and type 2 diabetes, the link between obesity and inflammation in patients with chronic kidney disease and the prognostic factors in pregnant...

  • Introduction and context: the past, present and future of CKD research. Locatelli, Francesco; Levin, Adeera // Nephrology Dialysis Transplantation;Oct2012 Supplement 3, Vol. 27 Issue suppl_3, piii1 

    No abstract available.

  • Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. Michel Chonchol; Massimo Cigolini; Giovanni Targher // Nephrology Dialysis Transplantation;Jan2008, Vol. 23 Issue 1, p269 

    Background. A potentially modifiable and underestimated risk factor for cardiovascular disease (CVD) in subjects with kidney dysfunction is 25-hydroxyvitamin D deficiency, although the relationship between inadequate vitamin D status and manifest CVD in type 2 diabetic subjects with mild kidney...

  • Serum Resistin and Kidney Function: A Family-Based Study in Non-Diabetic, Untreated Individuals. Menzaghi, Claudia; Salvemini, Lucia; Fini, Grazia; Thompson, Ryan; Mangiacotti, Davide; Di Paola, Rosa; Morini, Eleonora; Giorelli, Maddalena; De Bonis, Concetta; De Cosmo, Salvatore; Doria, Alessandro; Trischitta, Vincenzo // PLoS ONE;Jun2012, Vol. 7 Issue 6, p1 

    Background: High serum resistin levels have been associated with kidney dysfunction. Most of these studies have been carried out in individuals with severe kidney impairment, diabetes, cardiovascular disease and related treatments. Thus, the observed association might have been influenced by...

  • The Streptozotocin-Diabetic Rat as a Model of the Chronic Complications of Human Diabetes. Wei, Michael; Ong, Leslie; Smith, Maree T.; Ross, Fraser B.; Schmid, Katrina; Hoey, Andrew J.; Burstow, Darryl; Brown, Lindsay // Heart, Lung & Circulation;Mar2003, Vol. 12 Issue 1, p44 

    Background: Diabetes in humans induces chronic complications such as cardiovascular damage, cataracts and retinopathy, nephropathy and polyneuropathy. The most common animal model of human diabetes is streptozotocin (STZ)-induced diabetes in the rat. Methods: This project assessed...

  • Retinopathy in Type II diabetes mellitus associated with above-normal urinary excretion of RBP. Holm, Jan; Nielsen, Niels Vesti; Hemmingsen, Lars // Kidney International Supplement;Nov1994, Issue 47, pS-105 

    Retinopathy in Type II diabetes mellitus associated with above-normal urinary excretion of RBP, We performed a cross-sectional study on the urinary excretion profiles of albumin (a marker of glomerular dysfunction) and retinal-binding protein (a low molecular mass protein marker of renal...

  • Renal Nutrition Update. Steiber, Alison L. // Renal & Urology News;Nov2011, Vol. 10 Issue 11, p27 

    The article reports on the recognition of the medical nutrition therapy (MNT) for diabetes and kidney disease as a covered service for beneficiaries under Medicare Part B in the U.S. It outlines the requirements needed by the diabetics and patients suffering chronic kidney disease (CKD) to avail...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics